LOS ANGELES, CA, (NAMC) - After the close on Friday specialty pharmacy and medical specialty product provider DrugMax, Inc. (NASDAQ:DMAX) announced that they have received a non-compliance letter from the Nasdaq.

The letter stated that DrugMax shares have fell below the $1.00 per share Nasdaq listing requirement for the past 30 consecutive business days. The Nasdaq has given DrugMax 180 calendar days to rectify the situation or risk being delisted from the Nasdaq.

This falls under the Nasdaq Marketplace Rule 4310(c)(4).

In order to regain compliance the company must trade above $1.00 on the bid for a minimum of 10 consecutive business days.

DrugMax closed at 78 cents on Friday.

David Kingston
Los Angeles News Correspondent
NAMC Newswire
www.namcnewswire.com

This article can be republished either online or in print as long as credit is given to the author and the NAMC Newswire.
 
NAMC Newswire articles can now be listened to on StreetIQ.com
http://www.streetiq.com/dir/NAMC.shtml

To keep up to date with companies that we report on just register to receive the FREE Wall Street to Main Street Daily Newsletter. We feature companies that trade on the NYSE, AMEX, NASDAQ, OTCBB and Overseas, Keeping our readers informed daily. Just go to our site and register, it’s simple and free, www.namcnewswire.com/newsletter . Also be sure to visit the NAMC radio at www.namcnewswire.com/namcradio for the latest reports, interviews and corporate updates featured on the NAMC Newswire.